[Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association].
Antonia-Therese Kietaibl, Ingrid Schütz-Fuhrmann, Latife Bozkurt, Lisa Frühwald, Birgit Rami-Merhar, Elke Fröhlich-Reiterer, Sabine E Hofer, Martin Tauschmann, Michael Resl, Thomas Hörtenhuber, Lars Stechemesser, Yvonne Winhofer, Michaela Riedl, Sandra Zlamal-Fortunat, Marlies Eichner, Harald Stingl, Christian Schelkshorn, Raimund Weitgasser, Gersina Rega-Kaun, Gerd Köhler, Julia K Mader
{"title":"[Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association].","authors":"Antonia-Therese Kietaibl, Ingrid Schütz-Fuhrmann, Latife Bozkurt, Lisa Frühwald, Birgit Rami-Merhar, Elke Fröhlich-Reiterer, Sabine E Hofer, Martin Tauschmann, Michael Resl, Thomas Hörtenhuber, Lars Stechemesser, Yvonne Winhofer, Michaela Riedl, Sandra Zlamal-Fortunat, Marlies Eichner, Harald Stingl, Christian Schelkshorn, Raimund Weitgasser, Gersina Rega-Kaun, Gerd Köhler, Julia K Mader","doi":"10.1007/s00508-024-02400-x","DOIUrl":null,"url":null,"abstract":"<p><p>People living with diabetes mellitus can be supported in the daily management by diabetes technology with automated insulin delivery (AID) systems to reduce the risk of hypoglycemia and improve glycemic control as well as the quality of life. Due to barriers in the availability of AID-systems, the use and development of open-source AID-systems have internationally increased. This technology provides a necessary alternative to commercially available products, especially when approved systems are inaccessible or insufficiently adapted to the specific needs of the users. Open-source technology is characterized by worldwide free availability of codes on the internet, is not officially approved and therefore the use is on the individual's own responsibility. In the clinical practice a lack of expertise with open-source AID technology and concerns about legal consequences, lead to conflict situations for health-care professionals (HCP), sometimes resulting in the refusal of care of people living with diabetes mellitus. This position paper provides an overview of the available evidence and practical guidance for HCP to minimize uncertainties and barriers. People living with diabetes mellitus must continue to be supported in education and diabetes management, independent of the chosen diabetes technology including open-source technology. Check-ups of the metabolic control, acute and chronic complications and screening for diabetes-related diseases are necessary and should be regularly carried out, regardless of the chosen AID-system and by a multidisciplinary team with appropriate expertise.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11358222/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiener Klinische Wochenschrift","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00508-024-02400-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/28 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
People living with diabetes mellitus can be supported in the daily management by diabetes technology with automated insulin delivery (AID) systems to reduce the risk of hypoglycemia and improve glycemic control as well as the quality of life. Due to barriers in the availability of AID-systems, the use and development of open-source AID-systems have internationally increased. This technology provides a necessary alternative to commercially available products, especially when approved systems are inaccessible or insufficiently adapted to the specific needs of the users. Open-source technology is characterized by worldwide free availability of codes on the internet, is not officially approved and therefore the use is on the individual's own responsibility. In the clinical practice a lack of expertise with open-source AID technology and concerns about legal consequences, lead to conflict situations for health-care professionals (HCP), sometimes resulting in the refusal of care of people living with diabetes mellitus. This position paper provides an overview of the available evidence and practical guidance for HCP to minimize uncertainties and barriers. People living with diabetes mellitus must continue to be supported in education and diabetes management, independent of the chosen diabetes technology including open-source technology. Check-ups of the metabolic control, acute and chronic complications and screening for diabetes-related diseases are necessary and should be regularly carried out, regardless of the chosen AID-system and by a multidisciplinary team with appropriate expertise.
胰岛素自动输送(AID)系统可为糖尿病患者的日常管理提供糖尿病技术支持,从而降低低血糖风险,改善血糖控制和生活质量。由于自动胰岛素给药系统的可用性存在障碍,国际上对开源自动胰岛素给药系统的使用和开发日益增多。这种技术为商用产品提供了一种必要的替代方案,尤其是在无法使用已获批准的系统或系统不能充分满足用户特殊需求的情况下。开放源码技术的特点是可以在全球范围内通过互联网免费获取代码,但未经官方批准,因此使用时需个人自行负责。在临床实践中,由于缺乏使用开源辅助工具技术的专业知识以及对法律后果的担忧,导致医护人员(HCP)之间出现冲突,有时甚至导致糖尿病患者拒绝接受治疗。本立场文件概述了现有证据,并为医护人员提供实用指导,以尽量减少不确定性和障碍。糖尿病患者必须继续在教育和糖尿病管理方面得到支持,无论选择哪种糖尿病技术,包括开源技术。对代谢控制、急性和慢性并发症的检查以及糖尿病相关疾病的筛查都是必要的,无论选择哪种 AID 系统,都应由具备适当专业知识的多学科团队定期进行。
期刊介绍:
The Wiener klinische Wochenschrift - The Central European Journal of Medicine - is an international scientific medical journal covering the entire spectrum of clinical medicine and related areas such as ethics in medicine, public health and the history of medicine. In addition to original articles, the Journal features editorials and leading articles on newly emerging topics, review articles, case reports and a broad range of special articles. Experimental material will be considered for publication if it is directly relevant to clinical medicine. The number of international contributions has been steadily increasing. Consequently, the international reputation of the journal has grown in the past several years. Founded in 1888, the Wiener klinische Wochenschrift - The Central European Journal of Medicine - is certainly one of the most prestigious medical journals in the world and takes pride in having been the first publisher of landmarks in medicine.